Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIO-025 dose-ranging study with Pegasys in treatment-naive chronic hepatitis C
2006-002695-17Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alisporivir in hepatitis C virus infection (4 arms), sponsored by Debiopharm. Primary endpoints: Maximum log10 viral load reduction and Safety and tolerability. Started Nov 2006; status: completed.
02
Drugs
alisporivir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-002695-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002695-17.